Literature DB >> 22389236

Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial.

Robin K Kelley, Ryutaro Hirose, Alan P Venook.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22389236     DOI： 10.1002/lt.23423

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  4 in total

Review 1.  Liver transplantation for hilar cholangiocarcinoma.

Authors:  Ricardo Robles; Francisco Sánchez-Bueno; Pablo Ramírez; Roberto Brusadin; Pascual Parrilla
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

2.  A patient with cholangiocarcinoma demonstrating pathologic complete response to chemotherapy: exploring the role of neoadjuvant therapy in biliary tract cancer.

Authors:  Evan J Walker; Jeffry P Simko; Eric K Nakakura; Andrew H Ko
Journal:  J Gastrointest Oncol       Date:  2014-12

3.  Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Authors:  Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-20       Impact factor: 46.802

4.  Neoadjuvant chemoradiotherapy followed by liver transplantation is a promising treatment for patients with unresectable hilar cholangiocarcinoma: A case report.

Authors:  Jun Wang; Halmurat Obulkasim; Xiaoping Zou; Baorui Liu; Yafu Wu; Xingyu Wu; Yitao Ding
Journal:  Oncol Lett       Date:  2018-12-28       Impact factor: 2.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.